Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
drug
|
| gptkbp:activeDuring |
gptkb:valdecoxib
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:contraindication |
sulfa allergy
|
| gptkbp:dosageForm |
oral
|
| gptkbp:exportMarkets |
2005
|
| gptkbp:formulation |
tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bextra
|
| gptkbp:isA |
nonsteroidal anti-inflammatory drug
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:marketedAs |
gptkb:valdecoxib
|
| gptkbp:sideEffect |
cardiovascular events
skin reactions gastrointestinal issues |
| gptkbp:usedFor |
inflammation
pain relief |